1
|
Bangolo A, Wadhwani N, Nagesh VK, Dey S, Tran HHV, Aguilar IK, Auda A, Sidiqui A, Menon A, Daoud D, Liu J, Pulipaka SP, George B, Furman F, Khan N, Plumptre A, Sekhon I, Lo A, Weissman S. Impact of artificial intelligence in the management of esophageal, gastric and colorectal malignancies. Artif Intell Gastrointest Endosc 2024; 5:90704. [DOI: 10.37126/aige.v5.i2.90704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Revised: 01/28/2024] [Accepted: 03/04/2024] [Indexed: 05/11/2024] Open
Abstract
The incidence of gastrointestinal malignancies has increased over the past decade at an alarming rate. Colorectal and gastric cancers are the third and fifth most commonly diagnosed cancers worldwide but are cited as the second and third leading causes of mortality. Early institution of appropriate therapy from timely diagnosis can optimize patient outcomes. Artificial intelligence (AI)-assisted diagnostic, prognostic, and therapeutic tools can assist in expeditious diagnosis, treatment planning/response prediction, and post-surgical prognostication. AI can intercept neoplastic lesions in their primordial stages, accurately flag suspicious and/or inconspicuous lesions with greater accuracy on radiologic, histopathological, and/or endoscopic analyses, and eliminate over-dependence on clinicians. AI-based models have shown to be on par, and sometimes even outperformed experienced gastroenterologists and radiologists. Convolutional neural networks (state-of-the-art deep learning models) are powerful computational models, invaluable to the field of precision oncology. These models not only reliably classify images, but also accurately predict response to chemotherapy, tumor recurrence, metastasis, and survival rates post-treatment. In this systematic review, we analyze the available evidence about the diagnostic, prognostic, and therapeutic utility of artificial intelligence in gastrointestinal oncology.
Collapse
Affiliation(s)
- Ayrton Bangolo
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Nikita Wadhwani
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Vignesh K Nagesh
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Shraboni Dey
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Hadrian Hoang-Vu Tran
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Izage Kianifar Aguilar
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Auda Auda
- Department of Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Aman Sidiqui
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Aiswarya Menon
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Deborah Daoud
- Department of Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - James Liu
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Sai Priyanka Pulipaka
- Department of Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Blessy George
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Flor Furman
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Nareeman Khan
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Adewale Plumptre
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Imranjot Sekhon
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Abraham Lo
- Department of Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| | - Simcha Weissman
- Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
| |
Collapse
|
2
|
Noel OF, Dumbrava MG, Daoud D, Kammien AJ, Kauke-Navarro M, Pomahac B, Colen D. Vascularized Composite Allograft Versus Prosthetic for Reconstruction After Facial and Hand Trauma: Comparing Cost, Complications, and Long-term Outcome. Ann Plast Surg 2024; 92:100-105. [PMID: 37962243 DOI: 10.1097/sap.0000000000003731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2023]
Abstract
ABSTRACT In the past decade, vascularized composite allotransplantation (VCA) has become clinical reality for reconstruction after face and hand trauma. It offers patients the unique opportunity to regain form and function in a way that had only been achieved with traditional reconstruction or with the use of prostheses. On the other hand, prostheses for facial and hand reconstruction have continued to evolve over the years and, in many cases, represent the primary option for patients after hand and face trauma. We compared the cost, associated complications, and long-term outcomes of VCA with prostheses for reconstruction of the face and hand/upper extremity. Ultimately, VCA and prostheses represent 2 different reconstructive options with distinct benefit profiles and associated limitations and should ideally not be perceived as competing choices. Our work adds a valuable component to the general framework guiding the decision to offer VCA or prostheses for reconstruction after face and upper extremity trauma.
Collapse
Affiliation(s)
- Olivier F Noel
- From the Division of Plastic and Reconstructive Surgery, Yale-New Haven Hospital, Yale School of Medicine, New Haven, CT
| | | | - Deborah Daoud
- Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ
| | - Alexander J Kammien
- From the Division of Plastic and Reconstructive Surgery, Yale-New Haven Hospital, Yale School of Medicine, New Haven, CT
| | - Martin Kauke-Navarro
- From the Division of Plastic and Reconstructive Surgery, Yale-New Haven Hospital, Yale School of Medicine, New Haven, CT
| | - Bohdan Pomahac
- From the Division of Plastic and Reconstructive Surgery, Yale-New Haven Hospital, Yale School of Medicine, New Haven, CT
| | - David Colen
- From the Division of Plastic and Reconstructive Surgery, Yale-New Haven Hospital, Yale School of Medicine, New Haven, CT
| |
Collapse
|
3
|
Jain A, Daoud D, Kees-Folts D, Freeman MA, Butt F, Abendroth CS, Shike H, Kadry Z. Steroid-free maintenance immunosuppression using alemtuzumab in pediatric kidney transplantation: Long-term longitudinal follow-up. Pediatr Transplant 2022; 26:e14173. [PMID: 34687570 DOI: 10.1111/petr.14173] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/10/2021] [Revised: 08/17/2021] [Accepted: 10/05/2021] [Indexed: 12/01/2022]
Abstract
BACKGROUND There is a scarcity of long-term data on steroid-free immunosuppression using alemtuzumab in pediatric kidney transplantation (KTx). This study examines long-term outcomes with alemtuzumab without steroid maintenance therapy in pediatric KTx. METHODS From July 2005 to June 2015, 71 pediatric KTx recipients received alemtuzumab without steroid maintenance. They were followed from 4.1 to 14.1 years post KTx. RESULTS Patient survival: One child expired with a functioning graft from post-transplant lymphoproliferative disorder (PTLD). Patient survival was 98.6%. Graft survival: Eighteen grafts were lost (16 from chronic rejection). Graft survival at 5 and 10 years was 92.3% and 61.3%, respectively. Rejection: Twenty-three (32.4%) patients were free from T-cell-mediated rejection (TCMR), 16 (22.5%) had >3 episodes. Sixteen (22.5%) were treated for antibody-mediated rejection (AMR). Infection: Twenty-three children developed Epstein-Barr virus (EBV), 5 developed cytomegalovirus (CMV), and 20 developed BK virus infection. Four (5.6%) developed PTLD. Twenty-two (31.0%) required treatment for neutropenia. Growth parameters: Mean height and weight increased by 0.56 and 0.69 SDS (standard deviation score), respectively. Body mass index increased by 5.1 kg/m2 at 10 years. Less than 40% required antihypertensive medications at all-time points. CONCLUSION Alemtuzumab, without corticosteroid maintenance, offers 98.6% patient survival at 14 years with five and 10-year graft survival of 92.3% and 61.3%, respectively. TCMR and AMR requiring treatment were 67.4% and 22.5%, respectively. CMV, EBV, and BK viremia rates were 7.0%, 32.4%, and 28.2%, respectively. Thirty-one percent were treated for neutropenia; 5.6% developed PTLD. There were improvements in growth parameters and blood pressure.
Collapse
Affiliation(s)
- Ashokkumar Jain
- Division of Transplantation, Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
| | - Deborah Daoud
- Division of Transplantation, Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
| | - Deborah Kees-Folts
- Division of Pediatric Nephrology and Hypertension, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
| | - Michael A Freeman
- Division of Pediatric Nephrology and Hypertension, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
| | - Fauzia Butt
- Division of Transplantation, Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
| | - Catherine S Abendroth
- Department of Pathology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
| | - Hiroko Shike
- Department of Pathology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
| | - Zakiyah Kadry
- Division of Transplantation, Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
| |
Collapse
|
4
|
Patel JA, Daoud D, Jain A. Review of Standardized Incidence Ratios (SIR) of non-lymphoid de novo malignancies after liver transplantation: Structured analysis of global differences. Transplant Rev (Orlando) 2021; 36:100670. [PMID: 34688986 DOI: 10.1016/j.trre.2021.100670] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 10/13/2021] [Accepted: 10/14/2021] [Indexed: 12/16/2022]
Abstract
INTRODUCTION De Novo malignancy after liver transplantation (LTx) is the second most common cause of death in adult LTx recipients. The current report identifies differences in Standardized Incidence Ratios (SIR) for various non-lymphoid de novo malignancies by comparing and analyzing post LTx SIR for non-lymphoid de novo malignancies. MATERIAL AND METHODS A thorough search of PubMed and Web of Science databases was conducted; 25 publications describing de novo malignancies post-LTx with SIR were identified. RESULTS Overall SIR varied from 1.4 to 11.6 (median 2.4). Oropharyngeal/larynx (OPL), lung, colo-rectal, and kidney malignancies were more prevalent with higher SIR (median = 4.4, 1.9, 2.67, 2.5, respectively). Breast and prostate malignancies were also more prevalent with lower SIR (median = 0.9, 1.0, respectively). Pancreatic, central nervous system (CNS), melanoma, rare cancers and Kaposi's sarcoma were less prevalent (except in Italy and Sweden) but had much higher SIR (median = 2.6, 2.4, 2.02, 22.5 and 53.6, respectively). The overall higher SIR values are related to the age of the recipient, length of follow-up, the grouping of different organ systems, inclusion or exclusion of epidermal non-malacotic skin cancers, lymphoid malignancy, and occurrence of rare malignancies including Kaposi's sarcoma. CONCLUSION OPL, lung, gastrointestinal, kidney, and bladder malignancies were more prevalent with higher SIR. Breast and prostate cancers were more prevalent with lower SIR. Pancreatic, CNS, melanoma, rare cancers and Kaposi's sarcoma were less prevalent with higher SIR. Age of the recipients, length of follow-up, and rare cancer types influence overall SIR values with some global differences.
Collapse
Affiliation(s)
- Jay A Patel
- Department of General Surgery, The Pennsylvania State University, College of Medicine, Hershey, PA, USA
| | - Deborah Daoud
- Division of Transplant Surgery, The Pennsylvania State University, College of Medicine, Hershey, PA, USA
| | - Ashokkumar Jain
- Department of General Surgery, The Pennsylvania State University, College of Medicine, Hershey, PA, USA; Division of Transplant Surgery, The Pennsylvania State University, College of Medicine, Hershey, PA, USA.
| |
Collapse
|
5
|
Kashem M, Loor G, Hartwig M, Villavicencio-Theoduloz M, Axtell A, Sanchez P, Ryssel N, Huddleston S, Bottiger B, Daoud D, Zhao H, Wei Q, Bussetty A, Ius F, Warnecke G, Machuca T, Van Raemdonck D, Frick A, Neyrinck A, Chandrashekaran S, Toyoda Y. Extracorporeal Life Support Registry: Analysis of Ex Vivo Lung Perfusion Utilization in Donor after Cardiac Death and Donor after Brain Death. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
6
|
Ius F, Van Raemdonck D, Hartwig M, Bottiger B, Loor G, Daoud D, Wei Q, Villavicencio-Theoduloz M, Osho A, Chandrashekaran S, Machuca T, Neyrinck A, Toyoda Y, Kashem M, Huddleston S, Myers M, Sanchez P, Ryssel N, Warnecke G. Effect of Surgical Exposure on Outcomes in Lung Transplantation: Insight from the International Multicenter Extracorporeal Life Support (ECLS) in Lung Transplantation Registry. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.489] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
7
|
Kashem M, Loor G, Hartwig M, Villavicencio-Theoduloz M, Axtell A, Sanchez P, Ryssel N, Huddleston S, Bottiger B, Daoud D, Zhao H, Wei Q, Bussetty A, Ius F, Warnecke G, Machuca T, Van Raemdonck D, Frick A, Neyrinck A, Chandrashekaran S, Toyoda Y. Interim Results - The Effect of Donor Type (Donor after Cardiac Death vs Donor after Brain Death) and Use of Intraoperative Extracorporeal Lung Support on Survival after Lung Transplantation. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1900] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
8
|
Villavicencio M, Kashem M, Loor G, Hartwig M, Bottinger B, Ius F, Daoud D, Warnecke G, Wei Q, Chandrashekaran S, Machuca T, Van Raemdonck D, Neyrinck A, Huddleston S, Myers M, Moonsamy P, Toyoda Y. Impact of Cold Ischemic Time on Morbidity and Mortality after Lung Transplantation. An Updated Analysis of the International Multicenter Extracorporeal Life Support in Lung Transplantation Registry. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
9
|
Daoud D, Cartagena EMS, Somlaw N, Schwenger K, Gramlich L, Armstrong D, Raman M, Duerksen D, Whittaker S, Jurewitsch B, Marliss E, Allard J. A240 HOME PARENTERAL NUTRITION IN OLDER VERSUS YOUNGER PATIENTS: CLINICAL CHARACTERISTICS AND OUTCOMES. J Can Assoc Gastroenterol 2021. [DOI: 10.1093/jcag/gwab002.238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
There is a demographic shift toward older patients receiving home parenteral nutrition (HPN) but there is little data on their clinical characteristics and outcomes versus younger HPN patients.
Aims
The objective of this study was to determine if there are any differences between older (> 60 years) and younger (18–59 years) HPN patients in regard to HPN indications, prescriptions and outcomes over the first 2 years receiving HPN.
Methods
This was a retrospective analysis of prospectively collected data from HPN adult patients entered in the password protected web-based Canadian HPN Registry. New HPN patients enrolled between 2003 and 2017 and receiving HPN for 2 years were selected from 8 participating programs across Canada. Data included demographics, anthropometrics, PN prescriptions, line sepsis events, survival and quality of life based on the Karnofsky Performance Status (KPS).
Results
402 patients met the inclusion criteria: 184 patients were 60 years old or above (older group) and 219 patients were between 18 and 59 years old (younger group). Around 64% of both groups were female. There were no significant differences in the main indications for HPN, body mass index (BMI), and PN prescriptions at baseline. At 2-years, younger patients received more calories from PN than older patients (27.88 vs 19.56 Kcal/kg respectively, p <0.001) but BMI remained comparable between groups. There were less line sepsis in the older group versus the younger group (20% vs 36%, p=0.0023) but 78% of younger patients remained alive versus 69 % in the older group (p=0.0401). In those alive, the proportion of patients remaining on HPN was comparable (older group: 77%; younger; group 81%, p=0.4709) and the proportion of patients with a reasonable quality of life (KPS > 60) was similar (older group: 58%; younger group: 63%, p=0.2156).
Conclusions
Older HPN patients have similar clinical characteristics as younger patients but with reduced line sepsis events and higher 2-year mortality.
Funding Agencies
Ontario Medical Supply, Takeda, Fresenius Kabi and Baxter Inc
Collapse
Affiliation(s)
- D Daoud
- Centre Hospitalier de l’Université de Montréal - CHUM, Montréal, QC, Canada
| | | | - N Somlaw
- Chulalongkorn University, Bangkok, Bangkok, Thailand
| | | | - L Gramlich
- Community Services Centre, Edmonton, AB, Canada
| | | | - M Raman
- University of Calgary, Calgary, AB, Canada
| | - D Duerksen
- University of Manitoba, Winnipeg, MB, Canada
| | - S Whittaker
- The University of British Columbia Faculty of Medicine, Vancouver, BC, Canada
| | | | - E Marliss
- McGill University Faculty of Medicine, Montreal, QC, Canada
| | - J Allard
- Toronto General Hospital, Toronto, ON, Canada
| |
Collapse
|
10
|
Barinsky GL, Daoud D, Tan D, Cerasiello SY, Silva NA, Grube JG, Baredes S, Gray ST, Eloy JA. Gender Representation at Conferences, Executive Boards, and Program Committees in Otolaryngology. Laryngoscope 2020; 131:E373-E379. [PMID: 32673426 DOI: 10.1002/lary.28823] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Revised: 04/22/2020] [Accepted: 05/17/2020] [Indexed: 01/05/2023]
Abstract
OBJECTIVE Women represent approximately 28.0% of academic otolaryngologists. Previous studies have shown that women in academic medicine, including surgical subspecialties, have disparate career advancement opportunities and grant funding compared to male counterparts. Representation at major academic meetings is an important career advancement opportunity. In this study, we assess the representation of women at otolaryngology conferences. STUDY DESIGN Cross-sectional analysis of otolaryngology conference programs. METHODS All publicly available scientific programs from The American Academy of Otolaryngology-Head and Neck Surgery Foundation Annual Meeting (AAO-HNSF), the Triological Society Annual Combined Sections Meeting (TS), and the Triological Society Annual Meeting at Combined Otolaryngology Spring Meetings (TS-COSM) were obtained and analyzed. Name and gender were collected, along with the type of role: speaker, panelist, oral session moderator, and other leadership positions. Yearly trends were analyzed and compared between the conferences and in aggregate. RESULTS AAO-HNSF had available scientific programs from 2012-2017, while TS and TS-COSM had programs available from 2003-2018. Across all conferences and years, 16.9% of recorded opportunities were occupied by women, with an upward trend from 2005 to 2018. Program committees had the highest proportion of women (21.4%) and presidential citation and guest of honor recipients had the lowest (9.1%). Of all panels, 87.5% did not have any women panelists in 2003, but by 2018 only 24.0% panels were male-only. There was marked repetition among women occupying roles, with only 423 unique women occupying a total of 1,733 filled spots. CONCLUSION Measured representation of women in academic otolaryngology conferences has improved from 2003-2018. Despite this improvement, gender disparity still exists. LEVEL OF EVIDENCE 5 Laryngoscope, 131:E373-E379, 2021.
Collapse
Affiliation(s)
- Gregory L Barinsky
- Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A
| | - Deborah Daoud
- Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A
| | - Didem Tan
- Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A
| | - Samantha Y Cerasiello
- Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A
| | - Nicole A Silva
- Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A
| | - Jordon G Grube
- Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A
| | - Soly Baredes
- Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A.,Center for Skull Base and Pituitary Surgery, Neurological Institute of New Jersey, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A.,Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A
| | - Stacey T Gray
- Department of Otolaryngology - Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, U.S.A.,Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts, U.S.A
| | - Jean Anderson Eloy
- Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A.,Center for Skull Base and Pituitary Surgery, Neurological Institute of New Jersey, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A.,Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A.,Department of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A
| |
Collapse
|
11
|
Hartwig M, Loor G, Bottiger B, Warnecke G, Sommer W, Frick A, Neyrinck A, Villavicencio-Theoduloz M, Drezek K, Daoud D, Wei Q, Huddleston S, Landeweer M, Toyoda Y, Kashem M, Chandrashekaran S, Machuca T, Plascencia R, Smith M, Van Raemdonck D. Effect of Time of Intraoperative Circulatory Support on Incidence of High-Grade Primary Graft Dysfunction (PGD): Multicenter Analysis on Use of Extracorporeal Life Support (ECLS) during Lung Transplantation. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.346] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
12
|
Daoud D, Suter N, Durand M, Bouin M, Faulques B, Barkun AN, von Renteln D. A256 COMPARING GLOBAL OUTCOMES FOR ENDOSCOPIC SUBMUCOSAL DISSECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS. J Can Assoc Gastroenterol 2018. [DOI: 10.1093/jcag/gwy009.256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- D Daoud
- Centre Hospitalier de l’Université de Montréal (CHUM), Montréal, QC, Canada
| | - N Suter
- Centre Hospitalier de l’Université de Montréal (CHUM), Montréal, QC, Canada
| | - M Durand
- Centre Hospitalier de l’Université de Montréal (CHUM), Montréal, QC, Canada
| | - M Bouin
- Centre Hospitalier de l’Université de Montréal (CHUM), Montréal, QC, Canada
| | - B Faulques
- Centre Hospitalier de l’Université de Montréal (CHUM), Montréal, QC, Canada
| | - A N Barkun
- Gastroenterology, McGill University, The Montreal General Hospital, GI Division, Montreal, QC, Canada
| | - D von Renteln
- Centre Hospitalier de l’Université de Montréal (CHUM), Montréal, QC, Canada
| |
Collapse
|
13
|
Affiliation(s)
- D Daoud
- Centre Hospitalier de l’Université de Montréal - CHUM, Montréal, QC, Canada
| | - M Bouin
- Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada
| | - L Bellemare
- Gastroenterology, CHUM, Montréal, QC, Canada
| | - M Nemer
- Centre Hospitalier de l’Université de Montréal - CHUM, Montréal, QC, Canada
| |
Collapse
|
14
|
Bhat R, Patel H, Tsai PC, Sun XL, Daoud D, Lalancette RA, Michniak-Kohn B, Pietrangelo A. Effect of residue structure on the thermal and thermoresponsive properties of γ-substituted poly(N-acryloyl-2-pyrrolidones). Polym Chem 2015. [DOI: 10.1039/c5py00649j] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
We discuss the results of an investigation into the structure/property correlations of γ-substituted poly(N-acryloyl-2-pyrrolidone)s, a recently reported class of pyrrolidone-based polymers prepared from pyroglutamic acid, a bio-derived resource.
Collapse
Affiliation(s)
- R. Bhat
- Department of Chemistry
- Rutgers University-Newark
- Newark
- USA
| | - H. Patel
- Department of Chemistry
- Rutgers University-Newark
- Newark
- USA
| | - P.-C. Tsai
- Department of Pharmaceutics
- Ernest Mario School of Pharmacy
- Rutgers University
- Piscataway
- USA
| | - X.-L. Sun
- Department of Chemistry
- Rutgers University-Newark
- Newark
- USA
| | - D. Daoud
- Department of Chemistry
- Rutgers University-Newark
- Newark
- USA
| | | | - B. Michniak-Kohn
- Department of Pharmaceutics
- Ernest Mario School of Pharmacy
- Rutgers University
- Piscataway
- USA
| | - A. Pietrangelo
- Department of Chemistry
- Rutgers University-Newark
- Newark
- USA
| |
Collapse
|
15
|
Oueslati I, Manai H, Haddada F, Daoud D, Sánchez J, Osorio E, Zarrouk M. Sterol, Triterpenic Dialcohol, and Triacylglycerol Compounds of Extra Virgin Olive Oils from Some Tunisian Varieties Grown in the Region of Tataouine. FOOD SCI TECHNOL INT 2009. [DOI: 10.1177/1082013208101024] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The aim of this work was to study some of the chemical characteristics of virgin olive oils produced by three varieties grown in Tataouine (south of Tunisia). The oil samples studied were characterized by high levels of oleic acid (470%) and relatively low percentages of linoleic and palmitic acids (≤13% and ≤10%, respectively). They were also characterized by three primary triacylglycerols: OOO, POO, and OOL, and three secondary triacylglycerols POL + SLL, SOO, and PPO. The sterol and triterpenic dialcohol compositions of all the samples lay within the established regulatory limits. The main sterols found were b-sitosterol, Δ5-avenasterol, and campesterol. The amount of minor sterols present (24-methylenecholesterol, cholesterol, Δ7-avenasterol, and Δ7-stigmastenol) varied widely according to the varieties. The levels of erythrodiol + uvaol were below the upper legal limit of 4.5% in all analyzed samples. The results obtained showed that the great variability in oil composition among the varieties studied are influenced exclusively by the genetic factor.
Collapse
Affiliation(s)
- I. Oueslati
- Laboratoire Caractérisation et Qualité dé l'Huile d'Olive, Centre de Biotechnologie, Technopole de Borj-Cédria B.P. 901, Hammam-Lif 2050, Tunisia
| | - H. Manai
- Laboratoire Caractérisation et Qualité dé l'Huile d'Olive, Centre de Biotechnologie, Technopole de Borj-Cédria B.P. 901, Hammam-Lif 2050, Tunisia
| | - F.M. Haddada
- Laboratoire Caractérisation et Qualité dé l'Huile d'Olive, Centre de Biotechnologie, Technopole de Borj-Cédria B.P. 901, Hammam-Lif 2050, Tunisia
| | - D. Daoud
- Laboratoire Caractérisation et Qualité dé l'Huile d'Olive, Centre de Biotechnologie, Technopole de Borj-Cédria B.P. 901, Hammam-Lif 2050, Tunisia
| | - J. Sánchez
- Instituto Técnológico Agroaliméntario. Dirécción Général dé Infraestructuras y Desarrollo Tecnológico Junta dé Extremadura. Carretera dé Caceres s/n. Badajoz 06071, Spain
| | - E. Osorio
- Instituto Técnológico Agroaliméntario. Dirécción Général dé Infraestructuras y Desarrollo Tecnológico Junta dé Extremadura. Carretera dé Caceres s/n. Badajoz 06071, Spain
| | - M. Zarrouk
- Laboratoire Caractérisation et Qualité dé l'Huile d'Olive, Centre de Biotechnologie, Technopole de Borj-Cédria B.P. 901, Hammam-Lif 2050, Tunisia,
| |
Collapse
|
16
|
Bensadoun R, Daoud D, Bastit L, El-Gueddari B, Allavena C. 1102. Int J Radiat Oncol Biol Phys 2006. [DOI: 10.1016/j.ijrobp.2006.07.367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
17
|
Bensadoun RJ, Daoud D, Bastit L, El Gueddari B, Allavena C, Benidder A, Gourmet R, Ghabri S, Chaumont C, Dufour-Lamartinie JF. A controlled, multicenter randomised phase 3 study of an extended release miconazole (50mg) bioadhesive buccal tablet once daily for local treatment of oropharyngeal candidiasis in head and neck cancer patients undergoing radiation therapy. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.5527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- R.-J. Bensadoun
- Ctr Antoine-Lacassagne, Nice, France; CHU Habib Bourguiba, Sfax, Tunisia; Ctr Frédéric Joliot, Rouen, France; Inst National d’Oncologie Sidi Mohamed BenAbd., Rabat, Morocco; Ctr Catherine de Sienne, Nantes, France; Ctr d’oncologie Ibn Rachid, Casablanca, Morocco; Ctr Léon Bérard, Lyon, France; Clin et Statistica, Paris, France; Bioalliance Pharma, Paris, France
| | - D. Daoud
- Ctr Antoine-Lacassagne, Nice, France; CHU Habib Bourguiba, Sfax, Tunisia; Ctr Frédéric Joliot, Rouen, France; Inst National d’Oncologie Sidi Mohamed BenAbd., Rabat, Morocco; Ctr Catherine de Sienne, Nantes, France; Ctr d’oncologie Ibn Rachid, Casablanca, Morocco; Ctr Léon Bérard, Lyon, France; Clin et Statistica, Paris, France; Bioalliance Pharma, Paris, France
| | - L. Bastit
- Ctr Antoine-Lacassagne, Nice, France; CHU Habib Bourguiba, Sfax, Tunisia; Ctr Frédéric Joliot, Rouen, France; Inst National d’Oncologie Sidi Mohamed BenAbd., Rabat, Morocco; Ctr Catherine de Sienne, Nantes, France; Ctr d’oncologie Ibn Rachid, Casablanca, Morocco; Ctr Léon Bérard, Lyon, France; Clin et Statistica, Paris, France; Bioalliance Pharma, Paris, France
| | - B. El Gueddari
- Ctr Antoine-Lacassagne, Nice, France; CHU Habib Bourguiba, Sfax, Tunisia; Ctr Frédéric Joliot, Rouen, France; Inst National d’Oncologie Sidi Mohamed BenAbd., Rabat, Morocco; Ctr Catherine de Sienne, Nantes, France; Ctr d’oncologie Ibn Rachid, Casablanca, Morocco; Ctr Léon Bérard, Lyon, France; Clin et Statistica, Paris, France; Bioalliance Pharma, Paris, France
| | - C. Allavena
- Ctr Antoine-Lacassagne, Nice, France; CHU Habib Bourguiba, Sfax, Tunisia; Ctr Frédéric Joliot, Rouen, France; Inst National d’Oncologie Sidi Mohamed BenAbd., Rabat, Morocco; Ctr Catherine de Sienne, Nantes, France; Ctr d’oncologie Ibn Rachid, Casablanca, Morocco; Ctr Léon Bérard, Lyon, France; Clin et Statistica, Paris, France; Bioalliance Pharma, Paris, France
| | - A. Benidder
- Ctr Antoine-Lacassagne, Nice, France; CHU Habib Bourguiba, Sfax, Tunisia; Ctr Frédéric Joliot, Rouen, France; Inst National d’Oncologie Sidi Mohamed BenAbd., Rabat, Morocco; Ctr Catherine de Sienne, Nantes, France; Ctr d’oncologie Ibn Rachid, Casablanca, Morocco; Ctr Léon Bérard, Lyon, France; Clin et Statistica, Paris, France; Bioalliance Pharma, Paris, France
| | - R. Gourmet
- Ctr Antoine-Lacassagne, Nice, France; CHU Habib Bourguiba, Sfax, Tunisia; Ctr Frédéric Joliot, Rouen, France; Inst National d’Oncologie Sidi Mohamed BenAbd., Rabat, Morocco; Ctr Catherine de Sienne, Nantes, France; Ctr d’oncologie Ibn Rachid, Casablanca, Morocco; Ctr Léon Bérard, Lyon, France; Clin et Statistica, Paris, France; Bioalliance Pharma, Paris, France
| | - S. Ghabri
- Ctr Antoine-Lacassagne, Nice, France; CHU Habib Bourguiba, Sfax, Tunisia; Ctr Frédéric Joliot, Rouen, France; Inst National d’Oncologie Sidi Mohamed BenAbd., Rabat, Morocco; Ctr Catherine de Sienne, Nantes, France; Ctr d’oncologie Ibn Rachid, Casablanca, Morocco; Ctr Léon Bérard, Lyon, France; Clin et Statistica, Paris, France; Bioalliance Pharma, Paris, France
| | - C. Chaumont
- Ctr Antoine-Lacassagne, Nice, France; CHU Habib Bourguiba, Sfax, Tunisia; Ctr Frédéric Joliot, Rouen, France; Inst National d’Oncologie Sidi Mohamed BenAbd., Rabat, Morocco; Ctr Catherine de Sienne, Nantes, France; Ctr d’oncologie Ibn Rachid, Casablanca, Morocco; Ctr Léon Bérard, Lyon, France; Clin et Statistica, Paris, France; Bioalliance Pharma, Paris, France
| | - J.-F. Dufour-Lamartinie
- Ctr Antoine-Lacassagne, Nice, France; CHU Habib Bourguiba, Sfax, Tunisia; Ctr Frédéric Joliot, Rouen, France; Inst National d’Oncologie Sidi Mohamed BenAbd., Rabat, Morocco; Ctr Catherine de Sienne, Nantes, France; Ctr d’oncologie Ibn Rachid, Casablanca, Morocco; Ctr Léon Bérard, Lyon, France; Clin et Statistica, Paris, France; Bioalliance Pharma, Paris, France
| |
Collapse
|
18
|
Abstract
OBJECTIVE To study the efficacy of lamotrigine in relieving the pain associated with diabetic neuropathy. METHODS The authors randomly assigned 59 patients to receive either lamotrigine (titrated from 25 to 400 mg/day) or placebo over a 6-week period. Primary outcome measure was self-recording of pain intensity twice daily with a 0 to 10 numerical pain scale (NPS). Secondary efficacy measures included daily consumption of rescue analgesics, the McGill Pain Questionnaire (MPQ), the Beck Depression Inventory (BDI), the Pain Disability Index (PDI), and global assessment of efficacy and tolerability. RESULTS Twenty-four of 29 patients (83%) receiving lamotrigine and 22 of 30 (73%) patients receiving placebo completed the study. Daily NPS in the lamotrigine-treated group was reduced from 6.4 +/- 0.1 to 4.2 +/- 0.1 and in the control group from 6.5 +/- 0.1 to 5.3 +/- 0.1 (p < 0.001 for lamotrigine doses of 200, 300, and 400 mg). The results of the MPQ, PDI, and BDI remained unchanged in both groups. The global assessment of efficacy favored lamotrigine treatment over placebo, and the adverse events profile was similar in both groups. CONCLUSIONS Lamotrigine is effective and safe in relieving the pain associated with diabetic neuropathy.
Collapse
Affiliation(s)
- E Eisenberg
- Pain Relief Unit, Rambam Medical Center, The Technion-Israel Institute of Technology, Haifa, Israel.
| | | | | | | | | |
Collapse
|
19
|
Dagash M, Nakhoul F, Daoud D, Hayek T, Green J. The spectrum of "cerebral hyponatremia"--cerebral salt wasting syndrome in a patient with pituitary adenoma. Isr Med Assoc J 2000; 2:865-7. [PMID: 11344762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Affiliation(s)
- M Dagash
- Department of Internal Medicine E, Rambam Medical Center and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
| | | | | | | | | |
Collapse
|
20
|
Israel O, Gips S, Lubushitzky R, Bettman L, Iosilevsky G, Hardoff R, Baron E, Daoud D, Kolodny GM, Front D. Prediction of bone loss in patients with primary hyperparathyroidism using quantitative bone SPECT. J Nucl Med 1998; 39:1614-7. [PMID: 9744354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
UNLABELLED Bone loss is a major complication of primary hyperparathyroidism (PHPT), and it has significant implications in the treatment of this disease. Bone turnover was measured in patients with PHPT, using quantitative bone SPECT (QBS), to determine if the rate of bone loss could be predicted before a significant decrease in bone mass occurs. METHODS Forty-six patients were included in the study. QBS and bone mineral density (BMD) of the lumbar spine (LS) and femoral neck (FN) were done at baseline. The percent deviation of QBS in patients with PHPT from the values in normal matched controls was calculated. BMD was measured again after a mean of 17.5 mo in 38 patients, and in 29 patients a repeat BMD study was done after a mean of 41.4 mo. The change in BMD in patients with high and normal QBS values was compared using the nonparametric Mann-Whitney test. Regression analysis tested the correlation between baseline QBS values and BMD changes over time. RESULTS For the FN, there was a statistically significant difference in the BMD change between patients with high and normal QBS values for short-term follow-up (-2.82%+/-4.80% versus 1.45%+/-4.67%, p < 0.05) and for long-term follow-up (-3.53%+/-5.34% versus 0.92%+/-2.40, p < 0.02). There was a negative correlation in the FN, r=-0.48 between QBS values and the percentage of change in BMD. There was no significant difference between the percentage of change in BMD in the LS in patients with high and normal QBS values for either short- or long-term follow-up. CONCLUSION The results of this study show that QBS can predict bone loss in the FN in patients with PHPT. QBS can thus indicate the need for surgery at an early stage of the disease to prevent bone loss.
Collapse
Affiliation(s)
- O Israel
- Department of Nuclear Medicine, Rambam Medical Center and Carmel Lady Davis Hospital, Haifa, Israel
| | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Abstract
An open trial was conducted to study the potential efficacy of lamotrigine, a novel antiepileptic agent that blocks voltage-sensitive sodium channels and inhibits the release of glutamate, in relieving the pain associated with diabetic neuropathy. Subsequent to a 1 week washout period from previous analgesics, lamotrigine was administered at a dose of 25 mg/day for 1 week. The dose was doubled on a weekly basis up to 400 mg/day over 6 weeks. The McGill pain questionnaire (MPQ), spontaneous pain and a series of mechanical and thermal stimuli-induced pain were measured with the use of 0-100 visual analogue scale (VAS), on seven office visits. Pain level was also recorded by each patient twice daily, 1 week before, during, and 2 weeks after the treatment period with the use of a 0-10 numerical pain scale (NPS). Quantitative mechanical (Von Frey filaments) and thermal testing (QTT), and routine blood tests were performed at the beginning and at the end of the study. Thirteen patients completed the study. Spontaneous pain measured by VAS and NPS gradually dropped from a baseline of 49 +/- 8 and 6.8 +/- 0.6, to 20 +/- 8.6 (p < 0.001) and 4.3 +/- 0.9 (p < 0.001), respectively, at the end of the treatment period. Similarly, cold allodynia dropped from 38 +/- 9.2 to 16 +/- 15.3 (p = 0.01), and the MPQ score from 13.6 +/- 0.8 to 11.0 +/- 1.5 (p < 0.01). In contrast, no significant changes were found in the QTT, mechanical pain thresholds and laboratory results. Two patients were withdrawn from the study because of adverse effects. A long-term follow up showed that most patients were still using lamotrigine 6 months after the end of the study. The results of the study suggest that lamotrigine is potentially effective and safe in treating painful diabetic neuropathy. Copyright Rapid Science Ltd
Collapse
Affiliation(s)
- E Eisenberg
- Pain Relief Clinic, Rambam Medical Center, The Technion-Israel Institute of Technology, Haifa, Israel
| | | | | | | | | |
Collapse
|
22
|
Daoud D, Karnieli E. [The role of combined therapy by insulin and hypoglycemic drugs in diabetes]. Harefuah 1993; 124:281-285. [PMID: 8495920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
23
|
Abstract
Acanthosis nigricans (AN) with insulin resistance has been traditionally attributed to insulin receptor abnormalities. To further clarify the postbinding defects of in vivo insulin action in this state, we applied the euglycemic insulin clamp technique, combined with the glucose trace infusion method, to 26 subjects: 12 AN patients (eight normoglycemic and four hyperglycemic), eight obese, and eight lean control subjects. The normoglycemic AN group exhibited fasting hyperinsulinemia (666% of control), 160% elevated hepatic glucose production (HGP), 425% increased posthepatic insulin delivery rate, and only slightly reduced (19%) insulin clearance rates, compared with controls. Except for the latter, all these abnormalities were statistically significant (P less than .05), and could not be accounted for by body overweight. AN patients with diabetes mellitus (AN + DM) exhibited a further decreased insulin responsiveness (30%) and clearance (38%), together with a major increase in HGP (320%). All AN patients showed a significant right-shift in the insulin dose-response curve, indicating a decrease in insulin sensitivity. In conclusion, AN is characterized by increased basal rates of HGP, and peripheral insulin resistance, which can be partially attributed to postbinding defects. In AN + DM, a worsening of these abnormalities may be responsible for unmasking the existence of diabetes.
Collapse
Affiliation(s)
- P Cohen
- Department of Internal Medicine C, Rambam Medical Center, Haifa, Israel
| | | | | | | | | | | | | | | |
Collapse
|
24
|
|
25
|
Daoud D, Fox N, Tan J. Alteration in nail pigment after chemotherapy. Arch Intern Med 1977; 137:1259. [PMID: 901099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|